Bacterin International, Inc. Announces Preclinical Results On The Use Of Osteoselect® DBM Putty Published In The Journal Of Craniofacial Surgery
4/23/2014 9:37:02 AM
BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announced today that positive results utilizing OsteoSelect® Demineralized Bone Matrix Putty bone graft for cranial defect repair has been published in the peer-reviewed Journal of Craniofacial Surgery. This is the first peer reviewed publication evaluating the performance of OsteoSelect® DBM to date.
Help employers find you! Check out all the jobs and post your resume.
comments powered by